Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
18.54
+0.19 (1.04%)
Feb 4, 2026, 12:57 PM EST - Market open

Sabra Health Care REIT Statistics

Total Valuation

SBRA has a market cap or net worth of $4.62 billion. The enterprise value is $7.02 billion.

Market Cap4.62B
Enterprise Value 7.02B

Important Dates

The next confirmed earnings date is Thursday, February 12, 2026, after market close.

Earnings Date Feb 12, 2026
Ex-Dividend Date Feb 13, 2026

Share Statistics

SBRA has 249.35 million shares outstanding. The number of shares has increased by 2.41% in one year.

Current Share Class 249.35M
Shares Outstanding 249.35M
Shares Change (YoY) +2.41%
Shares Change (QoQ) +1.09%
Owned by Insiders (%) 1.68%
Owned by Institutions (%) 99.35%
Float 245.08M

Valuation Ratios

The trailing PE ratio is 25.45 and the forward PE ratio is 25.68. SBRA's PEG ratio is 2.68.

Price/FFO Ratio 12.56
Price/AFFO Ratio n/a
PE Ratio 25.45
Forward PE 25.68
PS Ratio 5.85
Forward PS 6.00
PB Ratio 1.62
P/TBV Ratio 1.67
P/FCF Ratio n/a
P/OCF Ratio 13.56
PEG Ratio 2.68
Financial Ratio History

Enterprise Valuation

EV / Earnings 40.12
EV / Sales 9.40
EV / EBITDA 15.41
EV / EBIT 24.85
EV / FCF n/a

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.92.

Current Ratio 2.99
Quick Ratio 2.62
Debt / Equity 0.92
Debt / EBITDA 5.70
Debt / FCF n/a
Interest Coverage 2.54

Financial Efficiency

Return on equity (ROE) is 6.28% and return on invested capital (ROIC) is 5.27%.

Return on Equity (ROE) 6.28%
Return on Assets (ROA) 3.23%
Return on Invested Capital (ROIC) 5.27%
Return on Capital Employed (ROCE) 5.19%
Weighted Average Cost of Capital (WACC) 6.53%
Revenue Per Employee $14.94M
Profits Per Employee $3.50M
Employee Count50
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, SBRA has paid $1.73 million in taxes.

Income Tax 1.73M
Effective Tax Rate 0.98%

Stock Price Statistics

The stock price has increased by +8.81% in the last 52 weeks. The beta is 0.65, so SBRA's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change +8.81%
50-Day Moving Average 19.00
200-Day Moving Average 18.46
Relative Strength Index (RSI) 39.86
Average Volume (20 Days) 2,385,001

Short Selling Information

The latest short interest is 22.77 million, so 9.13% of the outstanding shares have been sold short.

Short Interest 22.77M
Short Previous Month 22.71M
Short % of Shares Out 9.13%
Short % of Float 9.29%
Short Ratio (days to cover) 9.53

Income Statement

In the last 12 months, SBRA had revenue of $747.06 million and earned $175.08 million in profits. Earnings per share was $0.73.

Revenue747.06M
Gross Profit 497.79M
Operating Income 282.60M
Pretax Income 176.78M
Net Income 175.08M
EBITDA 455.63M
EBIT 282.60M
Earnings Per Share (EPS) $0.73
Full Income Statement

Balance Sheet

The company has $204.42 million in cash and $2.60 billion in debt, with a net cash position of -$2.40 billion or -$9.61 per share.

Cash & Cash Equivalents 204.42M
Total Debt 2.60B
Net Cash -2.40B
Net Cash Per Share -$9.61
Equity (Book Value) 2.83B
Book Value Per Share 11.33
Working Capital 233.57M
Full Balance Sheet

Cash Flow

Operating Cash Flow 341.15M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.63%, with operating and profit margins of 37.83% and 23.44%.

Gross Margin 66.63%
Operating Margin 37.83%
Pretax Margin 23.66%
Profit Margin 23.44%
EBITDA Margin 60.99%
EBIT Margin 37.83%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 6.47%.

Dividend Per Share $1.20
Dividend Yield 6.47%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 164.72%
Buyback Yield -2.41%
Shareholder Yield 4.06%
Earnings Yield 3.78%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SBRA is $20.75, which is 11.92% higher than the current price. The consensus rating is "Hold".

Price Target $20.75
Price Target Difference 11.92%
Analyst Consensus Hold
Analyst Count 8
Revenue Growth Forecast (5Y) 10.77%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6